Therapeutic efficacy of TMS-19-Q·GC tablet on respiratory tract infection

Seiichi Aonuma; Kikuo Onuma; Akira Watanabe; Masako Sasaki; Kotaro Oizumi; Kiyoshi Konno; Kosaku Nagai

doi:10.11250/chemotherapy1953.32.Supplement6_245

Therapeutic efficacy of TMS-19-Q·GC tablet on respiratory tract infection

Seiichi Aonuma, Kikuo Onuma, Akira Watanabe, Masako Sasaki, Kotaro Oizumi, Kiyoshi Konno, Kosaku Nagai

Research output: Contribution to journal › Article › peer-review

Abstract

A total of five patients with respiratory tract infections, one each patient having pneumonia, acute bronchitis, acute tonsillitis and two having pharyngitis, were treated with oral administration of TMS-19-Q·GC at a daily dose of 600mg for five to 23 days. Clinical response was good in three of the patients and fair in the remaining two patients. No adverse symptom and sign was noted during the administration of the drug.

Original language	English
Pages (from-to)	245-247
Number of pages	3
Journal	Chemotherapy
Volume	32
DOIs	https://doi.org/10.11250/chemotherapy1953.32.Supplement6_245
Publication status	Published - 1984 Jan 1

ASJC Scopus subject areas

Pharmacology (medical)
Infectious Diseases
Pharmacology
Drug Discovery
Oncology

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.11250/chemotherapy1953.32.Supplement6_245

Cite this

@article{8799090650f14dce88e75af7bfa78d8c,

title = "Therapeutic efficacy of TMS-19-Q·GC tablet on respiratory tract infection",

abstract = "A total of five patients with respiratory tract infections, one each patient having pneumonia, acute bronchitis, acute tonsillitis and two having pharyngitis, were treated with oral administration of TMS-19-Q·GC at a daily dose of 600mg for five to 23 days. Clinical response was good in three of the patients and fair in the remaining two patients. No adverse symptom and sign was noted during the administration of the drug.",

author = "Seiichi Aonuma and Kikuo Onuma and Akira Watanabe and Masako Sasaki and Kotaro Oizumi and Kiyoshi Konno and Kosaku Nagai",

year = "1984",

month = jan,

day = "1",

doi = "10.11250/chemotherapy1953.32.Supplement6_245",

language = "English",

volume = "32",

pages = "245--247",

journal = "CHEMOTHERAPY",

issn = "0009-3165",

}

TY - JOUR

T1 - Therapeutic efficacy of TMS-19-Q·GC tablet on respiratory tract infection

AU - Aonuma, Seiichi

AU - Onuma, Kikuo

AU - Watanabe, Akira

AU - Sasaki, Masako

AU - Oizumi, Kotaro

AU - Konno, Kiyoshi

AU - Nagai, Kosaku

PY - 1984/1/1

Y1 - 1984/1/1

N2 - A total of five patients with respiratory tract infections, one each patient having pneumonia, acute bronchitis, acute tonsillitis and two having pharyngitis, were treated with oral administration of TMS-19-Q·GC at a daily dose of 600mg for five to 23 days. Clinical response was good in three of the patients and fair in the remaining two patients. No adverse symptom and sign was noted during the administration of the drug.

AB - A total of five patients with respiratory tract infections, one each patient having pneumonia, acute bronchitis, acute tonsillitis and two having pharyngitis, were treated with oral administration of TMS-19-Q·GC at a daily dose of 600mg for five to 23 days. Clinical response was good in three of the patients and fair in the remaining two patients. No adverse symptom and sign was noted during the administration of the drug.

UR - http://www.scopus.com/inward/record.url?scp=0021219312&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0021219312&partnerID=8YFLogxK

U2 - 10.11250/chemotherapy1953.32.Supplement6_245

DO - 10.11250/chemotherapy1953.32.Supplement6_245

M3 - Article

AN - SCOPUS:0021219312

VL - 32

SP - 245

EP - 247

JO - CHEMOTHERAPY

JF - CHEMOTHERAPY

SN - 0009-3165

ER -

Therapeutic efficacy of TMS-19-Q·GC tablet on respiratory tract infection

Abstract

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this